Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Asthma and Primary Arterial Hypertension: an Inflammatory Link?

Key facts

Where
Tradate, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT07903805, who can take part

Where in Italy

  • IRCSS ICS Maugeri TradateTradate, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Istituti Clinici Scientifici Maugeri SpA
Trial code
NCT07903805
Record updated
30 October 2026
Original description
A low-intervention, prospective, experimental study will be conducted with the overall aim of assessing the inflammatory, functional and clinical differences between patients with asthma and those with asthma and hypertension, in order to improve our understanding of asthma and its comorbiditiesRead full original descriptionShow less

A low-intervention, prospective, experimental study will be conducted with the overall aim of assessing the inflammatory, functional and clinical differences between patients with asthma and those with asthma and hypertension, in order to improve our understanding of asthma and its comorbidities

Inclusion: Age ≥18 and ≤85 years; Diagnosis of moderate/severe asthma according to current Global Initiative for Asthma (GINA) guidelines; Diagnosis of moderate/severe asthma according to current GINA guidelines and primary arterial hypertension according to current European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines; Patients able to collaborate in the required procedures; Signed informed consent.

Exclusion: History of asthma exacerbation requiring changing of pharmacological treatment in the previous month; Diagnosis of concomitant Chronic Obstructive Pulmonary Disease (COPD); Obstructive Sleep Apnoea Syndrome (OSA); Clinically significant bronchiectasis; Allergic bronchopulmonary aspergillosis (ABPA); Atopic dermatitis; Diagnosis of concomitant Autoimmune Diseases; History of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), or (Hepatitis C Virus)HCV ; Active significant infection; Malignancy, current or within the past 5 years. Suspected malignancy or undefined neoplasms; Cognitive impairment; History of clinically significant chronic heart diseases; Active smoking status or ex-smoker with Pack/Year major than 10; BMI major than 30 Kg/m2; Pregnancy.

ClinicalTrials.gov NCT07903805